Microvessel density in prostatic hyperplasia

BJU International

Volumn 85, Issue 1, 2000, Pages 70-73

  Foley, S J ^a,c   Bailey, D M ^b  

^a ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

^b WYCOMBE HOSPITAL   (United Kingdom)

^c NONE   (United Kingdom)

Author keywords

Benign prostatic hyperplasia; Haematuria; Microvessel density

Indexed keywords

ADULT; AGED; ARTICLE; CATHETERIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITY; HEMATURIA; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROVASCULATURE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; TRANSURETHRAL RESECTION;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; HEMATURIA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROCIRCULATION; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE; PROSTATIC HYPERPLASIA;

EID: 0033968905     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2000.00322.x     Document Type: Article

References (21)

1. 1 Mebust WK, Holtgrewe HL, Cockett ATK, Peters PC & the Writing Committee. Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 1989; 141: 243
2. 2 Lynch TH, Waymont B, Dunn JJ, Hughes MA, Wallace DMA. Rapid diagnostic service for patients with haematuria. Br J Urol 1994; 73: 147-51
3. 3 Hasan ST, German K, Derry CD. Same day diagnosis of haematuria. Br J Urol 1994; 73: 151-4
4. 4 Marshall S, Narayan P. Treatment of prostatic bleeding: suppression of angiogenesis by androgen deprivation. J Urol 1993; 149: 1553
5. 5 Bettencourt MC, Bauer JJ, Sesterhenn IA, Connelly RR, Moul JW. CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy. J Urol 1998; 160: 459-65
6. 6 Gettman MT, Bergstralh EJ, Blute M, Zincke H, Bostwick DG. Prediction of patient outcome in pathologic stage T2 adenocarcinoma of the prostate: lack of significance for microvessel density analysis. Urology 1998; 51: 79-85
7. 7 Bostwick DG, Iczkowski KA. Microvessel density in prostate cancer: prognostic and therapeutic utility. Semin Urol Oncol 1998; 16: 118-23
8. 8 Campbell SC. Advances in angiogenesis research: relevance to urological oncology. J Urol 1997; 158: 1663-74
9. 9 Brawer MK. Quantitative microvessel density. A staging and prognostic marker for human prostatic carcinoma. Cancer 1996; 78: 345-9
10. 10 Kirschner CV, Alanis-Amezcua JM, Martin VG et al. Angiogenesis factor in endometrial carcinoma: a new prognostic indicator? Am J Obstet Gynecol 1996; 174: 1879-82
11. 11 Dray TG, Hardin NJ, Sofferman RA. Angiogenesis as a prognostic marker in early head and neck cancer. Ann Otol Rhinol Laryngol 1995; 104: 724-9
12. 12 Weidner N. Tumor angiogenesis: review of current applications in tumor prognostication. Semin Diagn Pathol 1993; 10: 302-13
13. 13 Saez C, Gonzalez-Baena AC, Japon MA et al. Regressive changes in finasteride-treated human hyperplastic prostates correlate with an upregulation of TGF-beta receptor expression. Prostate 1998; 37: 84-90
14. 14 Monti S, Sciarra F, Adamo MV et al. Prevalent decrease of the EGF content in the periurethral zone of BPH tissue induced by treatment with finasteride or flutamide. J Androl 1997; 18: 488-94
15. 15 Storey MT, Livingston B, Baeten L et al. Cultured human prostate derived fibroblasts produce a factor that stimulates their growth with properties indistinguishable from fibroblast growth factor. Prostate 1989; 15: 355
16. 16 Storey MT, Sasse J, Jacobs SC, Lawson RK. Prostatic growth factor: purification and structural relationship to basic fibroblast growth factor. Biochemistry 1987; 26: 3843
17. 17 Storey MT, Esch F, Shimasaki S, Sasse J, Jacobs SC, Lawson RK. Amino-terminal sequence of a large form of basic fibroblast growth factor isolated from human benign prostatic hyperplastic tissue. Biochem Biophys Res Commun 1987; 142: 702
18. 18 Puchner PJ, Miller MI. The effects of finasteride on haematuria associated with benign prostatic hyperplasia: a preliminary report. J Urol 1995; 154: 1779
19. 19 Kashif KM, Foley SJ, Basketter V, Holmes SAV. Haematuria in BPH - natural history and a new treatment option. Prostate Cancer Prostate Dis 1998; 1: 154-6
20. 20 Cardillo M, Berchem C, Tarkington MA et al. Resistance to apoptosis and up regulation of BcI-2 in benign prostatic hyperplasia after androgen deprivation. J Urol 1997; 158: 212-6
21. 21 Moon S-Y, Moon W-C, Choi HR et al. Finasteride inhibits angiogenesis and expression of VEGF in human prostates. AUA Proceedings 1998;abstractno. 1276